Mureletecan Uses, Dosage, Side Effects and more
Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With Metastatic Solid Tumors).
Trade Name | Mureletecan |
Generic | Mureletecan |
Mureletecan Other Names | Mureletecan |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |